• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新疆和黑龙江地区肾病综合征的流行病学特征及预后分析研究

Analysis and Study on Epidemiological Features and Prognosis of Nephrotic Syndrome in Xinjiang and Heilongjiang.

机构信息

Nephrology, Daqing Oilfield General Hospital, Daqing City, Heilongjiang Province 163000, China.

Nephrology, People's Hospital of Shache County, Kashgar, Xinjiang Uygur Autonomous Region 844700, China.

出版信息

Comput Math Methods Med. 2021 Nov 24;2021:8802670. doi: 10.1155/2021/8802670. eCollection 2021.

DOI:10.1155/2021/8802670
PMID:34868346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8635878/
Abstract

BACKGROUNDS

The pathogenesis of nephrotic syndrome (NS) is complex, and there are differences between regions. This study attempted to collect clinicopathological data of patients diagnosed with NS in Xinjiang and Heilongjiang in the past 2 years, so as to explore the onset features of NS and treatment and prognosis of patients in the two regions.

METHODS

Clinical data of 375 patients diagnosed with NS using renal biopsy in Xinjiang and Heilongjiang from March 2019 to March 2021 were collected. Clinical data of patients before treatment were collected, and the chi-square test was utilized to compare the differences in the sex distribution of two groups. The test was utilized to compare abnormal distribution continuous data between two groups, such as age, hemoglobin, plasma albumin, proteinuria, and triglycerides. Independent sample -test was utilized to compare normal distribution continuous data between two groups, such as serum total protein, serum creatinine, blood urea nitrogen, glomerular filtration rate, and total cholesterol. The independent sample -test was also used to compare the immunoglobulin levels and complement levels between the two groups after treatment, including IgA, IgG, IgM, C3, and C4. Kaplan-Meier method was used to analyze and plot the cumulative curves of complete remission rate and partial remission rate.

RESULTS

For 275 NS patients from Xinjiang, the male-to-female ratio was 0.81 : 1. For 84 patients from Heilongjiang, the male-to-female ratio was 1.05 : 1. The onset ages of patients in Xinjiang and Heilongjiang were 22-45 years old and 22-47 years old, respectively. Respectively, there were 221 cases (80.36%) and 66 cases (78.57%) of primary NS in Xinjiang and Heilongjiang. There were 54 cases (19.64%) and 18 cases (21.43%) of secondary NS in Xinjiang and Heilongjiang, respectively. There was no statistically significant difference in cause distribution between the two regions ( = 0.756). After treatment, immunoglobulin levels (IgA ( = 0.009), IgG ( = 0.002), IgM ( < 0.001)) and complement C3 ( < 0.001) and C4 ( < 0.001) levels in Xinjiang and Heilongjiang were statistically significant. 129 cases in Xinjiang (46.91%) and 55 cases in Heilongjiang (65.48%) were treated with glucocorticoid (GC) combined with immunosuppressive therapy, respectively. After receiving treatment, 67 (24.36%) of 275 patients in Xinjiang achieved complete remission, 166 (60.36%) achieved partial remission, 22 (26.19%) of 84 patients in Heilongjiang achieved complete remission, and 56 (66.67%) achieved partial remission, and there was no statistically significant difference in remission rate between the two regions ( = 0.159). Patients in Xinjiang and Heilongjiang achieved complete remission at an average of 10.34 weeks (9.98-10.70) and 9.95 weeks (9.26-10.65), respectively. There was no significant difference in complete remission rates between the two regions ( = 0.663). Patients in Xinjiang and Heilongjiang achieved partial remission at an average of 8.76 weeks (8.38-9.14) and 7.99 weeks (7.33-8.65), respectively. There was no significant difference in the partial remission rate between the two regions ( = 0.065).

CONCLUSION

The causes of NS in Xinjiang and Heilongjiang were similar. After treatment, there were differences in immunoglobulin levels (IgA, IgG, IgM) and complement levels (C3, C4) in the two regions. The main treatment methods used in the two regions were GC combined with immunosuppressive therapy. The prognosis of patients in the two regions was similar. The complete remission rate and partial remission rate after treatment in the two regions were similar, and the average time required to achieve complete remission and partial remission was also similar.

摘要

背景

肾病综合征(NS)的发病机制复杂,地区间存在差异。本研究试图收集过去 2 年新疆和黑龙江地区经肾活检诊断为 NS 的患者的临床病理资料,探讨 NS 的发病特征及两地区患者的治疗和预后。

方法

收集 2019 年 3 月至 2021 年 3 月新疆和黑龙江地区 375 例 NS 患者的临床资料,收集患者治疗前的临床资料,采用卡方检验比较两组患者的性别分布差异,采用秩和检验比较两组患者年龄、血红蛋白、血浆白蛋白、蛋白尿、三酰甘油等异常分布的连续性资料,采用独立样本 t 检验比较两组患者血清总蛋白、血清肌酐、血尿素氮、肾小球滤过率、总胆固醇等正态分布的连续性资料,采用独立样本 t 检验比较两组患者治疗后的免疫球蛋白和补体水平,包括 IgA、IgG、IgM、C3 和 C4。采用 Kaplan-Meier 法分析和绘制完全缓解率和部分缓解率的累积曲线。

结果

新疆 275 例 NS 患者中,男女性别比为 0.81∶1;黑龙江 84 例患者中,男女性别比为 1.05∶1。新疆和黑龙江地区患者发病年龄分别为 2245 岁和 2247 岁,分别有 221 例(80.36%)和 66 例(78.57%)为原发性 NS。新疆和黑龙江地区分别有 54 例(19.64%)和 18 例(21.43%)为继发性 NS。两组患者的病因分布差异无统计学意义(=0.756)。治疗后,新疆和黑龙江地区患者的免疫球蛋白水平(IgA=0.009,IgG=0.002,IgM<0.001)和补体 C3(<0.001)和 C4(<0.001)水平均有统计学差异。新疆 129 例(46.91%)和黑龙江 55 例(65.48%)患者采用糖皮质激素(GC)联合免疫抑制剂治疗。治疗后,新疆 275 例患者中 67 例(24.36%)达到完全缓解,166 例(60.36%)达到部分缓解,黑龙江 84 例患者中 22 例(26.19%)达到完全缓解,56 例(66.67%)达到部分缓解,两组患者的缓解率差异无统计学意义(=0.159)。新疆和黑龙江地区患者达到完全缓解的平均时间分别为 10.34 周(9.9810.70)和 9.95 周(9.2610.65),完全缓解率差异无统计学意义(=0.663)。新疆和黑龙江地区患者达到部分缓解的平均时间分别为 8.76 周(8.389.14)和 7.99 周(7.338.65),部分缓解率差异无统计学意义(=0.065)。

结论

新疆和黑龙江地区 NS 的病因相似,治疗后两组患者的免疫球蛋白水平(IgA、IgG、IgM)和补体水平(C3、C4)存在差异。两地区主要治疗方法均为 GC 联合免疫抑制剂治疗,两地区患者的预后相似,治疗后完全缓解率和部分缓解率相似,达到完全缓解和部分缓解所需的平均时间也相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7be/8635878/a50219fe9d39/CMMM2021-8802670.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7be/8635878/ed295d9886f7/CMMM2021-8802670.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7be/8635878/a50219fe9d39/CMMM2021-8802670.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7be/8635878/ed295d9886f7/CMMM2021-8802670.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7be/8635878/a50219fe9d39/CMMM2021-8802670.002.jpg

相似文献

1
Analysis and Study on Epidemiological Features and Prognosis of Nephrotic Syndrome in Xinjiang and Heilongjiang.新疆和黑龙江地区肾病综合征的流行病学特征及预后分析研究
Comput Math Methods Med. 2021 Nov 24;2021:8802670. doi: 10.1155/2021/8802670. eCollection 2021.
2
Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.IgA 肾病伴肾病综合征的临床特征和结局。
Clin J Am Soc Nephrol. 2012 Mar;7(3):427-36. doi: 10.2215/CJN.04820511. Epub 2012 Jan 5.
3
Interventions for idiopathic steroid-resistant nephrotic syndrome in children.儿童特发性类固醇抵抗性肾病综合征的干预措施。
Cochrane Database Syst Rev. 2019 Nov 21;2019(11):CD003594. doi: 10.1002/14651858.CD003594.pub6.
4
[Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].[中国儿童激素敏感、复发/激素依赖型肾病综合征诊断与治疗现状的多中心调查]
Zhonghua Er Ke Za Zhi. 2014 Mar;52(3):194-200.
5
A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.标准剂量泼尼松方案与霉酚酸酯联合较低剂量泼尼松用于乙肝表面抗原携带者的中国成人特发性肾病综合征患者的比较:一项前瞻性队列研究。
Clin Ther. 2009 Apr;31(4):741-50. doi: 10.1016/j.clinthera.2009.04.011.
6
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.霉酚酸酯治疗儿童激素抵抗型伴肾病综合征的IgA肾病
Pediatr Nephrol. 2015 Jul;30(7):1121-9. doi: 10.1007/s00467-014-3041-y. Epub 2015 Mar 15.
7
Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases.系膜IgM肾病的临床与免疫病理学研究:41例报告
Histopathology. 1984 May;8(3):435-46. doi: 10.1111/j.1365-2559.1984.tb02355.x.
8
[Remission of nephrotic syndrome in patients treated with corticosteroids and other immunosuppressive agents].[接受皮质类固醇及其他免疫抑制剂治疗的肾病综合征患者的缓解情况]
Med Arh. 2002;56(2):85-8.
9
Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.他克莫司治疗对类固醇和环磷酰胺耐药的成人肾病综合征且肾小球滤过率正常或轻度降低者。
Am J Kidney Dis. 2009 Jul;54(1):51-8. doi: 10.1053/j.ajkd.2009.02.018. Epub 2009 May 5.
10
Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.雷公藤(一种传统中药)用于原发性肾病综合征。
Cochrane Database Syst Rev. 2013 Aug 11(8):CD008568. doi: 10.1002/14651858.CD008568.pub2.

本文引用的文献

1
Spectrum of biopsy-proven renal disease in northern India: A single-centre study.印度北部经活检证实的肾脏疾病谱:一项单中心研究。
Nephrology (Carlton). 2020 Jan;25(1):55-62. doi: 10.1111/nep.13582. Epub 2019 May 6.
2
Association of Exposure to Fine-Particulate Air Pollution and Acidic Gases with Incidence of Nephrotic Syndrome.细颗粒物空气污染和酸性气体暴露与肾病综合征发病的关联。
Int J Environ Res Public Health. 2018 Dec 14;15(12):2860. doi: 10.3390/ijerph15122860.
3
Nephrotic Syndrome.肾病综合征
Pediatr Clin North Am. 2019 Feb;66(1):73-85. doi: 10.1016/j.pcl.2018.08.006.
4
Genetic Testing for Steroid-Resistant-Nephrotic Syndrome in an Outbred Population.远交群体中类固醇抵抗型肾病综合征的基因检测
Front Pediatr. 2018 Oct 22;6:307. doi: 10.3389/fped.2018.00307. eCollection 2018.
5
Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.长期暴露于空气污染与中国膜性肾病风险增加
J Am Soc Nephrol. 2016 Dec;27(12):3739-3746. doi: 10.1681/ASN.2016010093. Epub 2016 Jun 30.
6
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.日本肾活检登记处和日本肾脏病登记处:2009 年和 2010 年委员会报告。
Clin Exp Nephrol. 2013 Apr;17(2):155-73. doi: 10.1007/s10157-012-0746-8. Epub 2013 Feb 6.
7
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.免疫抑制治疗进展性膜性肾病:一项英国随机对照试验。
Lancet. 2013 Mar 2;381(9868):744-51. doi: 10.1016/S0140-6736(12)61566-9. Epub 2013 Jan 9.
8
Rituximab in idiopathic membranous nephropathy.利妥昔单抗治疗特发性膜性肾病。
J Am Soc Nephrol. 2012 Aug;23(8):1416-25. doi: 10.1681/ASN.2012020181. Epub 2012 Jul 19.
9
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.地理差异对 IgA 肾病遗传易感性的影响:GWAS 复制研究和地理空间风险分析。
PLoS Genet. 2012;8(6):e1002765. doi: 10.1371/journal.pgen.1002765. Epub 2012 Jun 21.
10
Prevalence of chronic kidney disease in China: a cross-sectional survey.中国慢性肾脏病患病率的横断面调查。
Lancet. 2012 Mar 3;379(9818):815-22. doi: 10.1016/S0140-6736(12)60033-6.